Table 7 Disadvantages of licensing use of m-RDT in community pharmacies
Items/statements | Disagree | Agree | Mean (SD) | ||
|---|---|---|---|---|---|
n | % | n | % | ||
People will not afford the cost of m-RDT and antimalarial in case of a positive test. | 156 | 78.0 | 44 | 22.0 | 1.22 (0.42) |
People will fear the finger prick necessary for needle injection | 149 | 74.5 | 51 | 25.5 | 1.25 (0.44) |
People will do self-treatments with antimalarial than never | 140 | 70.0 | 60 | 30.0 | 1.30 (0.46) |
People will tend to seek treatment in retail Pharmacies for even severe malaria | 104 | 52.0 | 96 | 48.0 | 1.48 (0.50) |
People will think Pharmacies want more money from the test | 119 | 59.5 | 81 | 40.5 | 1.41 (0.49) |
It will take more time to educate that a test is needed prior to antimalarial medicines | 98 | 49.0 | 102 | 51.0 | 1.51 (0.50) |
Regulatory authorities will not allow performing m-RDTs in Retail Pharmacies | 106 | 53.0 | 94 | 47.0 | 1.47 (0.50) |
Regulatory authorities will ask owners to hire lab technicians, thus additional cost. | 127 | 63.5 | 73 | 36.5 | 1.37 (0.48) |
Private health clinics will not like it | 93 | 46.5 | 107 | 53.5 | 1.53 (0.50) |
People will still ask for antimalarial medicines even when the test is negative. | 109 | 54.5 | 91 | 45.5 | 1.46 (0.50) |